EVISA - Who we are
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
adverse health effect
A change in body function or cell structure that might lead to disease or health problems.
ATSDR Glossary of Terms
The term "adverse health effect" was found in the following pages:
FDA identifies no harmful effects to date with brain retention of gadolinium-based contrast agents for MRIs | EVISA's News
Link database: CDC: Biomonitoring Summary: Molybdenum
Link database: CDC: Biomonitoring Summary: Antimony
See the complete list of deadlines!
Virtual: PittCon 2021: 72th Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy
New Orleans, LA
Atomic Spectroscopy Virtual Symposium 'A is for Arsenic'
Virtual: SETAC Europe 31st Annual Meeting
... more Events
What's new on EVISA's web site ?
Determination of gadolinium-based MRI contrast agents in fresh and oceanic waters of Australia
Effect of cooking on the speciation of chromium in food
Detoxification of Methylmercury in Higher Organisms
A universal method for the speciation analysis of arsenic in various seafoods
... more News
You have forgotten your password ?
© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )